Determinants of uptake of intermittent preventive treatment during pregnancy: a review

Abstract Malaria in pregnancy (MiP) contributes to devastating maternal and neonatal outcomes. Coverage of intermittent preventive treatment during pregnancy (IPTp) remains alarmingly low. Data was compiled from MiP programme reviews and performed a literature search on access to and determinants of...

Full description

Bibliographic Details
Published in:Malaria Journal
Main Authors: Elaine Roman, Kristin Andrejko, Katherine Wolf, Marianne Henry, Susan Youll, Lia Florey, Erin Ferenchick, Julie R. Gutman
Format: Article in Journal/Newspaper
Language:English
Published: BMC 2019
Subjects:
Malaria
Pregnancy
Intermittent preventive treatment
Sulfadoxine–pyrimethamine
Arctic medicine. Tropical medicine
RC955-962
Infectious and parasitic diseases
RC109-216
Arctic
Online Access:https://doi.org/10.1186/s12936-019-3004-7
https://doaj.org/article/c9c7b8eb94c84cb88602ec01d34ac546
Description
Summary:Abstract Malaria in pregnancy (MiP) contributes to devastating maternal and neonatal outcomes. Coverage of intermittent preventive treatment during pregnancy (IPTp) remains alarmingly low. Data was compiled from MiP programme reviews and performed a literature search on access to and determinants of IPTp. National malaria control and reproductive health (RH) policies may be discordant. Integration may improve coverage. Medication stock-outs are a persistent problem. Quality improvement programmes are often not standardized. Capacity building varies across countries. Community engagement efforts primarily focus on promotion of services. The majority of challenges can be addressed at country level to improve IPTp coverage.

Similar Items